To develop a repository of blood samples from patients with ILD to support future studies into the development of such biomarkers. Patients with pneumonia and healthy patients will also be recruited as a control group.
Interstitial Lung Disease
To develop a repository of blood samples from patients with ILD to support future studies into the development of such biomarkers. Patients with pneumonia and healthy patients will also be recruited as a control group.
Creation of a Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)
-
Mayo Clinic, Rochester, Minnesota, United States, 55905
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
Yes
Mayo Clinic,
Eva M Carmona Porquera, MD, PhD, PRINCIPAL_INVESTIGATOR, Mayo Clinic
2028-01